Matthew Scalo | executive |
Paul Diaz | executive |
Mark Verratti | executive |
Scott Leffler | executive |
Casey Woodring | analyst |
Andrew Cooper | analyst |
Jack Meehan | analyst |
David Westenberg | analyst |
Mason Carrico | analyst |
Kyle Boucher | analyst |
Puneet Souda | analyst |
Good day, and welcome to the Myriad Genetics Fourth Quarter 2023 Financial Earnings Call. [Operator Instructions] As a reminder, this call is being recorded. I would now like to turn the call over to Matt Scalo.
You may begin.
All right.